Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Current Treatment Options in Oncology|May 13, 2018
Promising New Agents for Colorectal CancerSatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.JNCI Cancer Spectrum|April 8, 2020
Germline Testing for Patients With <i>BRCA1/2</i> Mutations on Somatic Tumor TestingKatherine Vlessis, Natasha Purington, Nicolette Chun, et al.Immunotherapy|December 17, 2025
Multisystem immune-related adverse events during combined ipilimumab-nivolumab with subsequent disease progression: a case reportElsa Jonsdottir, Ivan Arni Robertsson, Agust Hilmarsson, et al.American Journal of Clinical Pathology|July 1, 2016
Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms: A Recommendation for Screening Synchronous/Metachronous NeoplasmsRachel M Roth, Sigurdis Haraldsdottir, Heather Hampel, et al.Laeknabladid|March 19, 2014
[Colorectal cancer - review]Sigurdis Haraldsdottir, Hulda M Einarsdottir, Agnes Smaradottir, et al.Acta Oncologica (Stockholm, Sweden)|January 31, 2025
Lynch syndrome screening in colorectal and endometrial cancers in IcelandKatla R Kluvers, Thordur Tryggvason, Vigdis Stefansdottir, et al.Familial Cancer|December 16, 2015
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasisSigurdis Haraldsdottir, Rachel Roth, Rachel Pearlman, et al.The Oncologist|August 4, 2018
Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair VariantsShyam A Patel, Teri A Longacre, Uri Ladabaum, et al.Laeknabladid|June 26, 2026
[Adjuvant endocrine therapy adherence in breast cancer patients diagnosed in Iceland 2013-2018]Gerður Eva Halldors Helgadottir, Anita Sol Valdimarsdottir, Stefania Katrin Finnsdottir, et al.Gastroenterology|September 8, 2014
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutationsSigurdis Haraldsdottir, Heather Hampel, Jerneja Tomsic, et al.Pageof 5